PMDA drug package insert
フジファミリー
PMDA OTC drug · （株）富士薬品 · package insert Oct 18, 2023
Key facts
| Brand names | フジファミリー |
|---|---|
| Companies | 製造販売元／（株）富士薬品 |
| Product type | OTC drug |
| OTC risk class | なし |
| OTC dosage form | 塗布剤 |
| OTC effect category | 皮膚軟化薬（吸出しを含む） |
| Package insert date | Oct 18, 2023 |
| PMDA document key | 670242_J1701000063 |
| PMDA company code | 670242 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: